Prescribing, recording, and reporting in endovascular brachytherapy. Quality assurance, equipment, personnel and education

Radiother Oncol. 2001 Jun;59(3):339-60. doi: 10.1016/s0167-8140(00)00335-2.

Abstract

Endovascular brachytherapy is a new, rapidly growing field of interest in radiotherapy for the prevention of neointimal hyperplasia after angioplasty in both coronary and peripheral arteries. Many physics aspects of these treatments have already been addressed in the report of the American Association of Physicists in Medicine task group on 'Intravascular brachytherapy', but up to now there are no generally accepted recommendations for recording and reporting radiation doses and volumes. The terminology to be used by all individuals involved in such treatments (radiation oncologists, physicists, and interventionalists) is not clearly defined. The Endovascular Groupe Européen de Curiethérapie/European Society for Therapeutic Radiology and Oncology Working Group in this document presents recommendations for a common language for general use in endovascular brachytherapy. This proposal addresses general terms and concepts for target and dose specification as well as detailed recommendations for dose prescription, recording and reporting in endovascular brachytherapy for both peripheral and coronary arteries. Additionally, quality assurance and radiation safety aspects are briefly addressed, as are aspects related to equipment, personnel, and training and education related to endovascular brachytherapy.

Publication types

  • Guideline
  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brachytherapy* / methods
  • Drug Prescriptions
  • Education, Professional
  • Equipment Safety
  • Europe
  • Health Personnel
  • Humans
  • Medical Records
  • Quality Assurance, Health Care
  • Radiation Oncology / organization & administration*